Influenza vaccines: a moving interdisciplinary field

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Influenza virus poses a significant threat to public health, causing widespread morbidity and mortality.
• Current influenza vaccines require annual updates due to the virus's antigenic variability, leading to immune escape.
• Existing vaccine production timelines are insufficient for rapid response during influenza pandemics.

Purpose of the Study:

• To explore novel strategies for improving influenza vaccine efficacy and accessibility.
• To address the limitations of current influenza vaccines in preventing infection and responding to pandemics.
• To investigate the potential of new technologies, adjuvants, and universal vaccines for enhanced influenza protection.

Main Methods:

• Review of current influenza vaccine technologies and production practices.
• Exploration of alternative vaccine production platforms and formulations.
• Discussion of the role of adjuvants in enhancing vaccine effectiveness and antigen-sparing.
• Consideration of universal vaccine approaches targeting conserved influenza epitopes.
• Highlighting the need for further immunological studies to redefine protection correlates.

Main Results:

• New technologies can accelerate vaccine seed strain production and availability.
• Adjuvants can enhance immune responses and enable antigen-sparing for wider vaccination coverage.
• Universal vaccines hold promise for long-term, broad protection against diverse influenza strains.
• Current research points towards the need to look beyond virus neutralization for protection correlates.

Conclusions:

• Advancements in vaccine technology, formulation, and the use of adjuvants are critical for a more effective and timely response to influenza.
• Universal influenza vaccines targeting conserved regions offer a promising strategy for durable and broad immunity.
• Further immunological research is essential to establish new correlates of protection beyond in vitro neutralization, improving future vaccine design.